Novartis' migraine drug gets EMA approval
admin 31st July 2018 Uncategorised 0Aimovig becomes Europe’s first treatment specifically designed to prevent migraine
More: Novartis' migraine drug gets EMA approval
Source: News
Aimovig becomes Europe’s first treatment specifically designed to prevent migraine
More: Novartis' migraine drug gets EMA approval
Source: News
© 1994 - 2023 B.M. Pharmaceuticals